| 000 | 01792 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516162335.0 | ||
| 264 | 0 | _c20131104 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(13)70309-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKreissman, Susan G | |
| 245 | 0 | 0 |
_aPurged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cSep 2013 |
||
| 300 |
_a999-1008 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunomagnetic Separation |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aNeuroblastoma _xmortality |
| 650 | 0 | 4 |
_aPeripheral Blood Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aRisk |
| 700 | 1 | _aSeeger, Robert C | |
| 700 | 1 | _aMatthay, Katherine K | |
| 700 | 1 | _aLondon, Wendy B | |
| 700 | 1 | _aSposto, Richard | |
| 700 | 1 | _aGrupp, Stephan A | |
| 700 | 1 | _aHaas-Kogan, Daphne A | |
| 700 | 1 | _aLaquaglia, Michael P | |
| 700 | 1 | _aYu, Alice L | |
| 700 | 1 | _aDiller, Lisa | |
| 700 | 1 | _aBuxton, Allen | |
| 700 | 1 | _aPark, Julie R | |
| 700 | 1 | _aCohn, Susan L | |
| 700 | 1 | _aMaris, John M | |
| 700 | 1 | _aReynolds, C Patrick | |
| 700 | 1 | _aVillablanca, Judith G | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 14 _gno. 10 _gp. 999-1008 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(13)70309-7 _zAvailable from publisher's website |
| 999 |
_c22951931 _d22951931 |
||